IPP Bureau
Granules India receives approval from Health Canada for arthritis drug
By IPP Bureau - August 30, 2021
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
Acute therapies drive overall pharma growth in July: Ind-Ra
By IPP Bureau - August 30, 2021
The segment delivered strong sales growth of 20% YoY
Visby Medical receives FDA approval and CLIA waiver for PCR sexual health test
By IPP Bureau - August 30, 2021
The Visby Medical sexual health click test is the first instrument-free PCR test for the detection of chlamydia, gonorrhoea and trichomonas, with results available within 30 minutes, during the patient visit
Union Minister Mansukh Mandaviya inaugurates Bharat Biotech’s Ankleshwar facility
By IPP Bureau - August 29, 2021
The facility has the capacity to produce one crore doses per day
DCGI approves Enzene biosimilar Denosumab for Osteoporosis
By IPP Bureau - August 28, 2021
This is Enzene Biosciences third biosimilar to be approved
Indian National Institute validates Livinguard’s face mask
By IPP Bureau - August 28, 2021
Textiles treated with the technology have also been proven to deactivate viruses, including SARS-CoV-2 (the virus that causes COVID-19).
European Commission grants market authorisation for BioMarin’s Voxzogo
By IPP Bureau - August 28, 2021
It is estimated that over 11,000 children across Europe, Middle East, and Africa are affected by achondroplasia and could be eligible for treatment with Voxzogo
South Asia’s first advanced Genomics Research Centre open in Hyderabad
By IPP Bureau - August 28, 2021
The centre established by Nucleome Informatics will take up the sequencing of 5,000 Covid genomes and 500 human genomes in the coming months
Max Healthcare to set up a 500-bed capacity hospital in Delhi
By IPP Bureau - August 28, 2021
This facility will integrate with existing Max hospitals and create a 2,300-bed contiguous medical hub spread over 23 acres. The first phase is to be ready by 2024
Covid-19 infected individuals need only one dose of Covaxin: ICMR study
By IPP Bureau - August 28, 2021
Blood samples were collected from 114 healthcare workers who received Covaxin in Chennai from February to May 2021
U.S. FDA approves drug-free VNS system for stroke
By IPP Bureau - August 28, 2021
When used alongside rehabilitative exercise, this device may offer benefit to those who have lost function in their upper limbs due to ischemic stroke
Japan approves AstraZeneca’s Forxiga for chronic kidney disease
By IPP Bureau - August 28, 2021
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
Marksans announces US FDA approval for Acetaminophen Extended- Release tablets
By IPP Bureau - August 27, 2021
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
Aurobindo subsidiary, Eugia gets US FDA approval for Cyclophosphamide injection
By IPP Bureau - August 27, 2021
The product will be available in 500 mg/2.5 mL and 1 g/5 mL vials
Rajasthan installs its first oxygen plant in Sikar
By IPP Bureau - August 27, 2021
To prevent the state from facing a shortage of medical oxygen and to bolster the existing infrastructure, the SRAM & MRAM group is actively helping the state government to set up oxygen plants in multiple cities
